FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula I and its pharmaceutically acceptable salt or solvate, a pharmaceutical composition based on them, as well as a method of treating or preventing a viral infection and a method of inhibiting virus production using them. In the general formula I, one of X1 and X2 is N and the other is S; X3 and X4 are independently selected from C and N; and when X3 is C, it is optionally substituted with isopropyl; one of R1 and R2 is H, and the other is a 5- or 6-membered aryl or cycloalkyl with 1-3 ring heteroatoms independently selected from N and O, and substituted with 0-2 groups independently selected from: =O, C1-6 straight or branched chain alkyl, optionally substituted with -OR12; or R1 and R2 together form an unsubstituted or 6-membered cycloalkyl with 2 ring heteroatoms representing O; R3 is selected from H, -C≡N, straight or branched C1-4 alkoxy, -SO2(C1-6 alkyl), and ring structure containing 5- or 6-membered aryl or 4-, 5- or a 6-membered cycloalkyl with 1 or 2 ring heteroatoms independently selected from N, O and S, and substituted with 0-2 groups independently selected from =O, C1-6 straight or branched chain alkyl, and C1-6 straight or branched chain alkoxy; R4 is selected from H, -C≡N, C1-4 straight or branched chain alkoxy, -SO2(C1-6 alkyl), -C(O)NH2, ring structure containing 5-membered aryl or 5 - or a 6-membered cycloalkyl with 2 ring heteroatoms independently selected from N, O and S, and substituted with 0-2 groups representing =O; R5 represents H; R6 represents H; and R12 is independently, in each case, selected from straight or branched chain C1-4 alkyl.
EFFECT: obtaining an anti-viral compositions of a wide spectrum of action and methods.
22 cl, 6 dwg, 2 tbl, 68 ex
Title | Year | Author | Number |
---|---|---|---|
N-(AZAARYL)CYCLOLACTAM-1-CARBOXAMIDE DERIVATIVE, ITS PREPARATION METHOD AND ITS APPLICATION | 2018 |
|
RU2765785C2 |
DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS CONTAINING THEM, OBTAINING AND APPLICATION | 2004 |
|
RU2346938C2 |
XIA FACTOR INHIBITORS | 2016 |
|
RU2728783C2 |
TRICYCLIC COMPOUNDS AFFECTING CRBN PROTEINS | 2019 |
|
RU2801068C2 |
DERIVATIVE WITH ARTICULATED RINGS AND METHOD FOR PREPARATION THEREOF, INTERMEDIATE COMPOUND, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 2016 |
|
RU2683566C1 |
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
ANTI-PROLIFERATIVE COMPOUNDS AND THEIR APPLICATIONS | 2019 |
|
RU2811969C2 |
NEW SUBSTITUTED BIARYL COMPOUNDS AS INDOLAMINE-2,3-DIOXYGENASE (IDO) INHIBITORS | 2018 |
|
RU2786586C2 |
HETEROCYCLIC MAT2A INHIBITORS AND METHODS OF THEIR USE FOR CANCER TREATMENT | 2019 |
|
RU2809987C2 |
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
Authors
Dates
2024-02-06—Published
2018-10-17—Filed